We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OCX market cap is 30.73M. The company's latest EPS is USD -3.4769 and P/E is -0.81.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 10.31M | 18.6M | -1.33M | 864k | -10.87M |
| Operating Income | 9.68M | 7.13M | -8.29M | 248k | -22.94M |
| Net Income | -45.5M | 3.03M | -8.33M | -7.23M | -16.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 5.23M | 7.73M | 31.98M | 7.27M |
| Operating Income | -22.52M | -31.26M | -74.48M | -18M | -23.85M |
| Net Income | -22.43M | -29.93M | -64.1M | -73.42M | -28.72M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 100.09M | 82.8M | 87.54M | 81.59M | 74.89M |
| Total Liabilities | 60.5M | 39.34M | 39.22M | 39.1M | 49.3M |
| Total Equity | 34.29M | 37.93M | 43.6M | 37.56M | 20.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 39.86M | 55.42M | 159.56M | 100.09M | 74.89M |
| Total Liabilities | 9.02M | 21.94M | 94.35M | 60.5M | 49.3M |
| Total Equity | 30.84M | 33.48M | 65.22M | 34.29M | 20.47M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -45.57M | -9.67M | -16.5M | -18.76M | -23.33M |
| Investing | -4.34M | N/A | 123k | -1.17M | -932k |
| Financing | 35.81M | -28k | 12.25M | 12.22M | 12.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -19.72M | -25.98M | -35.94M | -45.57M | -23.33M |
| Investing | -12.42M | -11.75M | -13.96M | -4.34M | -932k |
| Financing | 47.87M | 22.8M | 78.75M | 35.81M | 12.19M |
| Market Cap | 30.73M |
| Price to Earnings Ratio | -0.81 |
| Price to Sales Ratio | 3.22 |
| Price to Cash Ratio | 2.48 |
| Price to Book Ratio | 0.91 |
| Dividend Yield | - |
| Shares Outstanding | 8.26M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.19 (4.87%) |
| Company Name | OncoCyte Corporation |
| Address |
15 cushing irvine, california 92618 |
| Website | https://www.oncocyte.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
